IRIS - Res&Arch Institutional Research Information System - Research & Archive

IORIO, Alfonso
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.150
EU - Europa 8.381
AS - Asia 6.611
SA - Sud America 1.419
AF - Africa 114
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 15
Totale 27.713
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.705
SG - Singapore 2.897
IE - Irlanda 1.760
UA - Ucraina 1.704
HK - Hong Kong 1.309
BR - Brasile 1.207
RU - Federazione Russa 1.126
IT - Italia 929
SE - Svezia 864
CN - Cina 817
VN - Vietnam 781
DE - Germania 577
FI - Finlandia 538
CA - Canada 353
GB - Regno Unito 322
KR - Corea 269
TR - Turchia 130
FR - Francia 100
PL - Polonia 76
CH - Svizzera 69
AR - Argentina 66
AT - Austria 66
IN - India 58
UZ - Uzbekistan 57
MX - Messico 54
NL - Olanda 44
BD - Bangladesh 41
EC - Ecuador 39
ID - Indonesia 36
CO - Colombia 34
ZA - Sudafrica 34
CZ - Repubblica Ceca 31
IQ - Iraq 31
JP - Giappone 31
BE - Belgio 29
RO - Romania 28
ES - Italia 27
LB - Libano 27
GR - Grecia 21
PT - Portogallo 21
PY - Paraguay 21
PK - Pakistan 19
LT - Lituania 18
AE - Emirati Arabi Uniti 16
AU - Australia 16
MA - Marocco 16
SA - Arabia Saudita 15
VE - Venezuela 15
EU - Europa 14
NP - Nepal 14
KE - Kenya 12
PE - Perù 12
EG - Egitto 11
BG - Bulgaria 10
CL - Cile 10
DO - Repubblica Dominicana 9
UY - Uruguay 9
JO - Giordania 8
TN - Tunisia 8
AM - Armenia 7
HN - Honduras 7
KZ - Kazakistan 7
BO - Bolivia 6
DZ - Algeria 6
NZ - Nuova Zelanda 6
BH - Bahrain 5
IL - Israele 5
PA - Panama 5
PH - Filippine 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AZ - Azerbaigian 4
LU - Lussemburgo 4
OM - Oman 4
SN - Senegal 4
BF - Burkina Faso 3
CR - Costa Rica 3
DK - Danimarca 3
ET - Etiopia 3
SK - Slovacchia (Repubblica Slovacca) 3
BB - Barbados 2
GA - Gabon 2
GH - Ghana 2
GL - Groenlandia 2
KG - Kirghizistan 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
RS - Serbia 2
YE - Yemen 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
GE - Georgia 1
Totale 27.691
Salva come PNG Salva come JPEG
Città #
Dublin 1.759
Chandler 1.691
Singapore 1.667
Hong Kong 1.304
San Mateo 1.102
Jacksonville 769
Boardman 655
Santa Clara 507
Dong Ket 489
Medford 489
Princeton 486
Wilmington 368
Altamura 362
Andover 345
Ashburn 310
Lawrence 283
Moscow 283
Perugia 272
Seoul 268
Ottawa 266
Ann Arbor 242
Beijing 147
Des Moines 135
Saint Petersburg 130
Ho Chi Minh City 121
São Paulo 118
Piscataway 117
Los Angeles 109
Norwalk 108
Izmir 104
New York 93
Shanghai 84
Munich 83
Helsinki 82
Columbus 67
The Dalles 62
Falls Church 55
San Paolo di Civitate 54
Rio de Janeiro 51
Hanoi 44
Dallas 43
Warsaw 40
Woodbridge 38
Brooklyn 37
Chicago 37
London 33
Turku 33
Redwood City 31
Belo Horizonte 29
Brasília 28
Brussels 28
Montreal 27
Nuremberg 27
Phoenix 26
Amelia 25
Guangzhou 24
Johannesburg 24
San Diego 24
Milan 23
Tokyo 23
Dearborn 22
San Francisco 22
Stockholm 22
Curitiba 21
Houston 21
Redmond 21
Bucharest 20
Bogotá 19
Boston 19
Den Haag 19
Goiânia 19
Atlanta 18
Auburn Hills 18
Frankfurt Am Main 18
Salvador 18
Ribeirão Preto 17
Rome 17
Chennai 16
Denver 16
Narni 16
Terni 16
Vienna 16
Council Bluffs 14
Manchester 14
Mexico City 14
Amsterdam 13
Brno 13
Campinas 13
Frankfurt am Main 13
Haiphong 13
Porto Alegre 13
Tashkent 13
Cardiff 12
Dubai 12
Lausanne 12
Guarulhos 11
Santo André 11
Sorocaba 11
Zhengzhou 11
Ankara 10
Totale 16.915
Salva come PNG Salva come JPEG
Nome #
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 155
1286 Prospective consecutive cases of venous thromboembolic diseases at the single Venous thromboembolic Unit of Reggio Emilia 149
Interventions for enhancing medication adherence. 142
Oral anticoagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS) 138
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 136
. The role of thrombophilic states in the bleeding tendency of patients with hemophilia 109
Establishing the prevalence and prevalence at birth of hemophilia in males a meta-analytic approach using national registries 109
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial 109
Development and validation of the first treatment satisfaction scale for adult haemophiliacs (Hemo0-SatA) 108
Acute ketoacidosisin continuous subcutaneous insulin infusion treated Type 1 diabetics impairs the fibrynolytic capacity 106
Serine base exchange enzyme in commercially available porcine lyophilised platelets: different effect of unfractionated and low molecular weight heparins 104
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 104
Influenza vaccination in patients on long-term anticoagulant therapy. 102
Sindrome da anticorpi fosfolipidi. Descrizione di un caso clinico con trombosi atriale dx e revisione della casistica di Reggio Emilia 100
Thrombophilia and cerebral vein thrombosis 100
Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase. 100
A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation 100
I disordini congeniti ed acquisiti dell’emostasi e della fibrinolisi 98
Answering relevant research questions via careful observation of clinical practice: a fresh look at the old way forward. 98
OAT with POC devices and remote computer monitoring in the setting of the Italian NHS: a controlled clinical trial 97
Le trombofilie acquisite 96
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism 96
Effect of dermatan sulphate on activated partial thromboplastin time determined with different reagents 96
Audit clinico sull’impiego di plasma fresco congelato (PFC) in Umbria: disegno dello studio e risultati preliminari. 96
Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen 96
Prothrombin 202120A mutation in Behcet’s disease 95
LMWH or Ximelagatran versus VKA in the prevention of VTE after major knee surgery: a meta-analysis of randomized controlled trials 94
ACP Journal Club. A 9-factor score predicted 2-year risk for bleeding in outpatients with, or at high risk for, atherothrombosis. 94
A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol. 94
L’organizzazione del centro per il monitoraggio della terapia anticoagulante orale 93
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No 93
Influenza vaccination in patients on long-term anticoagulant therapy 92
Low-molecular-weight-heparin for the long term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulant 91
Systematic Review of Randomized Controlled Trials of Prophilactic Clotting Factor Concentrate in Hemophilia 91
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 91
Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study. 91
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors. 91
D-DIMER TO PREDICT RECURRENCE AFTER A FIRST EPISODE OF UNPROVOKED VENOUS THROMBOEMBOLISM: COMPARISON OF AGGREGATE AND INDIVIDUAL PATIENT DATA META-ANALYSIS 88
Audit of the clinical use of fresh-frozen plasma in umbria: study design and results. 87
A Predictive Model for the Development of High-Responding Inhibitor In Children with Severe and Moderate Hemophilia A- Results of a Multicenter Cohort Study. 87
D-DIMER TO PREDICT THROMBOSIS RECURRENCE: COMPARISON OF AGGREGATE DATA AND INDIVIDUAL PATIENT DATA META-ANALYSES. 86
IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY 85
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis. 85
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders. 85
D-DIMER TO PREDICT THROMBOSIS RECURRENCE AFTER UNPROVOKED VENOUS THROMBOEMBOLISM: EFFECT OF PATIENT- AND D-DIMER-RELATED FACTORS ON RECURRENCE PREDICTION 85
APTT evaluation in the presurgery screening: survey of 5000 patients 84
Sustained suppression of hepatitics C by pegylated Interferon (PEG-INF) and Ribavirin in hemophilic patients 84
Studio GEMINA: ruolo dei polimorfismi genetici e dell'omocisteinemia nell'infarto del miocardico in giovani-adulti italiani 84
Il monitoraggio della terapia anticoagulante orale 84
Prolonged antithrombin activity of low-molecular-weight heparins. Clinical implications for the treatment of thromboembolic diseases 84
Heparin reduces venous thromboembolism in neurosurgery but increases the risk of bleeding. (Iorio A, Agnelli G. Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a metanalysis. Arch Intern Med. 2000;160:2327-2332) 83
Genima study: genetic polymorphysms and myocardial infarction among italian young adults 83
HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY 83
The good use of plasma. A critical analysis of five international guidelines. 83
Bioequivalence of B-domain deleted and plasma derived FVIII concentrates. 83
ANTITHROMBOTIC PROPHYLAXIS IN ELDERLY PATIENTS ATRIAL FIBRILLATION ADMITTED TO INTERNAL MEDICINE WARDS IN ITALY: ADHERENCE TO GUIDELINES 83
Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo project 83
Low-molecular-weight heparin treatment and cancer: pooled analysis of 908 patients treated for three months 82
Terapia anticoagulante orale con l’impiego di tecnologia POC e monitoraggio via web nell’ambito del Sistema Sanitario Nazionale Italiano 82
Acute ketoacidosisin continuous subcutaneous insulin infusion treated Type 1 diabetics impairs the fibrynolytic capacity 82
Critical appraisal of five international guidelines on fresh frozen plasma clinical use. 82
Defective indoleamine 2,3-dioxygenase induction is associated with inhibitor development in severe hemophilia a patients carrying f8 gene null mutations. 82
Low molecular weight heparin for prevention of venous thromboembolism in elective neurosurgery: a metanalysis 81
RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS 81
Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence 81
Different mechanism regulate phosphatidylserine synthesis in rat cerebral cortex" 81
ACP Journal Club. The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care. 81
The association between venous thromboembolism and physical inactivity in everyday life 81
Switching patients in the age of long-acting recombinant products? 81
Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls 81
Gemina study:genetic polymorphysms and myocardial infarction among italian young adults 80
Risk factors for venous thromboembolism in patients undergoing elective neurosurgery 79
Clinical and laboratoristic performance evaluation of three point-of-care devices for INR determination (Coagucheck, ProTime, Harmony) 79
Hyperhomcysteinemia and other thrombophilic factors in Italian patients with inflammatory bowel disease 79
The effect of influenza vaccination in patients on long-term oral anticoagulant therapy 79
Systematic review of randomized controlled trials of prophylactic clotting factor concentrate in hemophilia 79
Prospective assessment of clinical endpoints of vka treatment in a primary care computer assisted management model. 79
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation. 79
Profilassi della trombosi venosa profonda in neurochirurgia 78
Oral Anticoagulants and small intestinal bacterial overgrowth 78
Clinical audit of the use of fresh frozen plasma in Umbria: study design and results of the pilot phase. 78
Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children: A Systematic Review and Meta-Analysis of Observational Studies 78
Haemophilia A and B and other rare bleeding disorders: an Italian retrospective survey on the intracranial haemorrhagic episodes. 78
Eradicazione del virus C dell'epatite (HCV) dopo terapia combinata con Interferone Pegilato (PEG-INF) e Rivabirina in pazienti emofilici HIV negativi 77
ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C IN HEMOPHILIA PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS 77
Factor V Leiden and G20210A prothrombin allele are not associated with thrombosis in Behcet’s disease 76
Low-molecular-weight-heparin for the long term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparison with oral anticoagulant 76
High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C 76
Computer assisted vka monitoring with point of care device by general practitioners. 76
Transition to a web-based architecture of the Italian hemophilia registry network. 76
Pharmacokinetics of plasma-derived vs. recombinant FVIII concentrates: a comparative study. 76
A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews 76
A comparison of methods for prediction of pharmacokinetics across factor concentrate switching in hemophilia patients 76
The D-dimer (DD) Test to Establish the Duration of Anticoagulation after a First Unprovoked Episode of Venuos Thromboembolism (VTE); the Prospective Randomized 'Prolong' Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA) 75
Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus. 75
INDOLEAMINA 2,3 DIOSSIGENASI E TOLLERANZA AL FATTORE VIII IN PAZIENTI AFFETTI DA EMOFILIA A GRAVE. 75
Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A 75
Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis 74
Venous thromboembolic disease: clinical reatures of 1282 prospective consecutive cases at angiology unit of Reggio Emilia 73
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B 73
Totale 8.906
Salva come PNG Salva come JPEG
Categoria #
all - tutte 142.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.809
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.579 0 0 0 0 0 165 220 8 303 98 247 538
2021/20223.740 51 742 92 140 123 36 64 1.372 34 25 445 616
2022/20235.912 541 887 95 415 472 660 8 302 2.251 10 193 78
2023/20242.084 157 229 108 36 36 14 507 125 211 82 238 341
2024/20255.072 20 621 63 140 714 106 88 419 1.145 344 1.009 403
2025/20264.776 786 573 628 1.433 1.025 331 0 0 0 0 0 0
Totale 28.419